Celcuity Inc. (CELC) vs Viking Therapeutics, Inc. (VKTX)
A side-by-side comparison of Celcuity Inc. and Viking Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELC
Celcuity Inc.
$71.21HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
VKTX
Viking Therapeutics, Inc.
$28.42HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
Total return — CELC vs VKTX
growth of $100 · dividends reinvested · last 9yCELC +415.2% (+20.0%/yr)VKTX +2381.4% (+42.9%/yr)VKTX compounded faster over this window
CELC VKTX
CELC vs VKTX: by the numbers
- •CELC is the larger company ($3.47B vs $3.32B market cap).
Metrics side by side
Valuation
| Metric | CELC | VKTX |
|---|---|---|
| P/B ratio | N/A | 8.12 |
Profitability
| Metric | CELC | VKTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -130.98% |
| ROIC | -28.15% | -135.85% |
Growth (annualized)
| Metric | CELC | VKTX |
|---|---|---|
| Total return CAGR (5Y) | 34.40% | 37.36% |
Frequently asked
- How have CELC and VKTX total returns compared?
- Over the past 5 years, CELC delivered 34.40% and VKTX delivered 37.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Celcuity ROEViking Therapeutics ROECelcuity operating marginViking Therapeutics operating marginCelcuity revenue growthViking Therapeutics revenue growthCelcuity free cash flowViking Therapeutics free cash flow
Celcuity & Viking Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.